GSA Capital Partners LLP lifted its stake in Dolby Laboratories (NYSE:DLB – Free Report) by 312.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,096 shares of the electronics maker’s stock after purchasing an additional 17,492 shares during the period. GSA Capital Partners LLP’s holdings in Dolby Laboratories were worth $1,483,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Hantz Financial Services Inc. grew its holdings in shares of Dolby Laboratories by 166.7% in the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock worth $25,000 after purchasing an additional 220 shares during the last quarter. Rothschild Investment LLC grew its holdings in shares of Dolby Laboratories by 4,046.7% in the third quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock worth $45,000 after purchasing an additional 607 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. bought a new position in shares of Dolby Laboratories in the third quarter worth about $50,000. Optiver Holding B.V. grew its holdings in shares of Dolby Laboratories by 7,955.6% in the third quarter. Optiver Holding B.V. now owns 725 shares of the electronics maker’s stock worth $52,000 after purchasing an additional 716 shares during the last quarter. Finally, Fifth Third Bancorp lifted its stake in Dolby Laboratories by 34.7% in the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after acquiring an additional 192 shares during the period. 58.56% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of research firms recently weighed in on DLB. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday, April 27th. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Rosenblatt Securities reaffirmed a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a research note on Friday, January 30th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, Dolby Laboratories currently has an average rating of “Moderate Buy” and an average target price of $90.75.
Insider Buying and Selling at Dolby Laboratories
In other Dolby Laboratories news, SVP Shriram Revankar sold 3,000 shares of the stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $54.90, for a total transaction of $164,700.00. Following the completion of the sale, the senior vice president directly owned 80,603 shares of the company’s stock, valued at approximately $4,425,104.70. This represents a 3.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP John D. Couling sold 7,666 shares of the stock in a transaction dated Tuesday, May 5th. The shares were sold at an average price of $57.55, for a total transaction of $441,178.30. Following the sale, the senior vice president directly owned 118,353 shares of the company’s stock, valued at approximately $6,811,215.15. The trade was a 6.08% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 20,249 shares of company stock valued at $1,157,434. 37.93% of the stock is currently owned by insiders.
Dolby Laboratories Price Performance
NYSE:DLB opened at $53.98 on Thursday. The firm has a market cap of $5.11 billion, a PE ratio of 21.34 and a beta of 0.86. The company has a 50-day moving average of $60.42 and a 200 day moving average of $63.50. Dolby Laboratories has a 1-year low of $52.45 and a 1-year high of $77.00.
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating the consensus estimate of $1.31 by $0.06. The business had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The company’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.34 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Sell-side analysts anticipate that Dolby Laboratories will post 3.22 EPS for the current fiscal year.
Dolby Laboratories Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were given a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend was Tuesday, May 12th. Dolby Laboratories’s dividend payout ratio is presently 56.92%.
Dolby Laboratories Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Read More
- Five stocks we like better than Dolby Laboratories
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
